BUFFALO, NY – Graham Warren, MD, PhD, will be joining the Department of Radiation Medicine and the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute (RPCI). “I am confident he will contribute significantly to Roswell Park in advancing the field of radiation medicine,” said Michael Kuettel, MD, PhD, MBA, the Barbara C. and George H. Hyde Chair in Radiation Medicine.
Dr. Warren comes to RPCI from the Department of Radiation Medicine, University of Kentucky (UK), where he completed his residency. He earned his Doctor of Philosophy degree in Toxicology in 1999 and a medical degree in 2004 at UK. Dr. Warren is eligible for certification by the American Board of Radiology and was named a Young Investigator by the American Society of Clinical Oncology in 2008.
His research interests focus on evaluation of radiosensitization and radioprotection pathways, molecular characterization of tumor response, clinical and laboratory evaluation of lung and head/neck cancers, biologic and physical modeling of mixed radioisotope brachytherapy sources, and laboratory and clinical evaluation of the relationship between nicotine exposure and tumor response, toxicity and patient survival.
Dr. Warren has authored or co-authored more than 40 peer-reviewed journal articles and abstracts and served as principal investigator or co-investigator on several clinical and basic science grants. Dr. Warren is a member of the American Society of Radiation Oncology (ASTRO), American Society of Clinical Oncology (ASCO), American Brachytherapy Society (ABS), Radiological Society of North America (RSNA), and the American Association for the Advancement of Science (AAAS).
The Department of Radiation Medicine at RPCI provides and ensures access to quality, state-of-the-art patient care; offers cutting-edge treatment through in-house protocols and participates in national studies; and trains future generations of physicians and paramedical professionals in radiation oncology. The team of specialists includes board-certified physicians, board-certified physicists, registered nurses, board-certified dosimetrists, board-certified technicians, and other support staff.
The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. RPCI, founded in 1898, was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. For more information, visit RPCI’s website at http://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or email email@example.com.
Annie Deck-Miller, Senior Media Relations Manager